Dabrafenib and Trametinib

Similar documents
Dabrafenib (Tafinlar )

Sorafenib (Nexavar ) For thyroid carcinoma

Sorafenib (Nexavar ) for hepatocellular carcinoma (HCC)

Pazopanib (Votrient ) oral for renal tumours

1. and it is more than 12 hours until your next dose, take the missed dose and continue with your normal schedule

Gemcitabine and Cisplatin (urology)

Ceritinib (Zykadia )

Tamoxifen Tamoxifen. Your treatment Your doctor or nurse clinician has prescribed for you a treatment which includes the hormonal therapy tamoxifen.

Afatinib (Giotrif ) Your treatment Your doctor has prescribed you a treatment called afatinib (Giotrif ) which is a tablet and is taken orally.

Methotrexate. You will have a routine blood test before the start of each cycle of treatment.

Nivolumab. Nivolumab

Oral cyclophosphamide in ovarian cancer

Mitomycin C given by injection into a vein. Cisplatin and hydration (fluids) via a drip over 6 or 18 hours.

Vinblastine (Lymphoma)

Weekly standard dose. Paclitaxel (Taxol) and carboplatin

Alectinib (Alecensa ) Alectinib (Alecensa )

Ibrutinib (Imbruvica )

High dose melphalan conditioning for autologous transplant (inpatient) Palatine treatment centre

Brentuximab vedotin. Brentuximab vedotin

Cisplatin and radiotherapy to the

Abemaciclib (Verzenios ) Abemaciclib (Verzenios )

Gemcitabine and carboplatin (Lung)

Bendamustine. Bendamustine. Your treatment Your doctor or nurse clinician has prescribed a course of treatment with bendamustine.

Capecitabine chemotherapy and concurrent radiotherapy to the pancreas

Vinorelbine (Oral) Oral Vinorelbine

Doxorubicin & Ifosfamide

Mitomycin C and Fluorouracil

Trastuzumab (Early breast cancer)

Carboplatin & weekly paclitaxel (Taxol) (for anal cancer) Carboplatin and weekly paclitaxel (Taxol) (for anal cancer)

455 Pemetrexed (Alimta ) cisplatin Page 1 of 6

Oral Etoposide (Lymphoma)

Paclitaxel (Taxol) Paclitaxel is given into the vein (intravenously) through a fine tube (cannula) as an infusion over 1 hour.

Obinutuzumab (lymphoma) Obinutuzumab (lymphoma)

tumours tumours Temozolamide and capecitabine for pancreatic neuroendocrine tumours

Your treatment. 240 BEP 3 Days Page 1 of 6

High dose cytarabine (Lymphoma)

Capecitabine (breast)

ALL Consolidation (cycles 1-4)

GDP GDP Gemcitabine, Dexamethasone, CisPlatin Your treatment Day 1 Days 1 to 4 Day 8 dexamethasone

Epirubicin. Epirubicin

Pemetrexed (Alimta )

Fluorouracil and calcium folinate (Includes MdG (Modified degramont))

1231 Zoledronic acid in early breast cancer Page 1 of 5

Gemcitabine and carboplatin (Breast)

Paclitaxel (Taxol) and carboplatin

Gemcitabine and carboplatin (Lung)

Cisplatin and gemcitabine (GI)

ABVD. by infusion over 30 minutes. You will have treatment on Day 1 and Day 15 of a 28 day cycle. You will have 2, 3 or 6 cycles.

Cisplatin and 5-Fluorouracil (Urology)

IVAC IVAC (Lymphoma) 1277 IVAC (Lymphoma) Page 1 of 6

GCVP. Cyclophosphamide by injection Vincristine by short infusion. Gemcitabine by infusion over 30 minutes

Myeloma Haematology and Transplant Unit

Erlotinib (Tarceva )

DHAP DHAP Your treatment dexamethasone Possible side effects

ChIVPP. ChIVPP. Day 1 to 14 Chlorambucil tablets Procarbazine capsules Prednisolone tablets

Pemetrexed (Alimta ) and cisplatin

The treatment is given every 3 weeks for 6 to 8 cycles.

Pentostatin (Nipent )

Mitomycin C by bolus [short] injection followed by capecitabine tablets which can be started the next day.

Eribulin (Halaven ) Treatment is given on Day 1 and Day 8 of a 21-day cycle.

Carboplatin and Capecitabine

Myeloma Haematology and Transplant Unit CTD1

Vincristine by short infusion Doxorubicin by injection Cyclophosphamide by injection Rituximab by an infusion over between 60 minutes to a few hours

ABVD. by infusion over 30 minutes. You will have treatment on Day 1 and Day 15 (this is one cycle) for 2, 3 or 6 cycles.

VDC IE. Your treatment You will have 14 cycles of VDC IE given every 2 to 3 weeks.

Capecitabine and radiotherapy (colo-rectal)

Myeloma Haematology and Transplant Unit MPT

Docetaxel (Taxotere) & Carboplatin

Cisplatin and Capecitabine

VIDE. Vincristine given via intravenous (IV) infusion over 10 minutes Etoposide & doxorubicin given together via IV infusion over 4 hours

MACE. Etoposide via an infusion (drip) over 1 hour, once a day for 5 days

Dabrafenib (Tafinlar )

ATORIS 10, 20, 40 mg film-coated tablets

Having a gastroscopy A guide for patients and their carers

Myocet. Myocet. Myocet is given into the vein (intravenously) through a fine tube (cannula) as an infusion over 1 hour.

Bexarotene for cutaneous T-cell lymphoma (CTCL) Information for patients

Docetaxel (Taxotere) with GCSF

Concurrent chemo-radiation for SCLC

For the Patient: Vemurafenib Other names: ZELBORAF

Insertion of a totally implantable vascular access device (TIVAD)

Pre-operative chemo-radiotherapy to the oesophagus (gullet) Paclitaxel (Taxol) and carboplatin

Ketorolac injection. Supportive care

Tacrolimus. Information for patients about using the drug Tacrolimus.

Information for patients having radiotherapy to the whole brain

Hyper-CVAD per CV Your treatment Your treatment is usually given over five days as an inpatient and consists of:

Nilotinib (nil ot' i nib) is a drug that is used to treat some types of cancer. It is a capsule that you take by mouth.

Patient guide to Capecitabine chemotherapy with radiotherapy for rectal cancer

For the Patient: Olaparib tablets Other names: LYNPARZA

Eribulin (Halaven ) Treatment is given on Day 1 and Day 8 of a 21-day cycle.

Chemo-radiotherapy to the stomach post operatively with Capecitabine

For the Patient: Ponatinib Other names: ICLUSIG

For the Patient: Everolimus tablets Other names: AFINITOR

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Sunitinib. Other Names: Sutent. About This Drug. Possible Side Effects. Warnings and Precautions

For the Patient: Cobimetinib tablets Other names: COTELLIC

Cyclophosphamide Treatment (To be used in conjunction with the Shared Care Blood Test Monitoring Card)

Capecitabine. Other Names: Xeloda. About This Drug. Possible Side Effects. Warnings and Precautions

Chelation therapy for iron overload in sickle cell and thalassaemia

Nivolumab. Other Names: Opdivo. About this Drug. Possible Side Effects (More Common) Warnings and Precautions

Transcription:

Dabrafenib and Trametinib Dabrafenib and Trametinib This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary. This treatment aims to control the cancer and its symptoms. Your doctor will explain to you the treatment and its side effects. Your doctor or nurse will be happy to answer any questions you have about your treatment. Your treatment Your doctor or nurse clinician has prescribed for you a targeted therapy called dabrafenib and trametinib. The treatment is suitable for patients with a specific mutation in their cancer. These drugs are taken in combination. You should continue to take the medication without interruption unless advised by your doctor or if you develop a high temperature while taking them. Your doctor will monitor your progress regularly while you are on this medication. This treatment can have serious or possibly life-threatening side effects. It is very important that you report side effects straight away. Don t delay; if you feel unwell, please ring The Christie Hotline on 0161 446 3658. The lines are open 24 hours a day. Please tell your doctor if you have:- liver or kidney problems diabetes eye problems or if you are on other medications. How is it taken? The medications should be swallowed whole with a full glass of water. It is important to take them on an empty stomach (one hour before food or two hours after food). The dabrafenib is to be taken twice daily as close to 12 hours apart as possible. The trametinib is to be taken once daily with either the morning or evening dose of dabrafenib. If you forget to take your medicine you may take it when you remember as long as it is not less than six hours before your next dose of dabrafenib and not less than 12 hours before your next dose of trametinib. Do not take double doses. If you vomit after your dose do not repeat the dose. You will need to have regular blood tests while taking this medication. Dabrafenib should be stored at room temperature away from heat, light and moisture. Trametinib should be stored in the fridge at 2 C 8 C. Please keep both medicines out of reach of children. Grapefruit and grapefruit juice can interact with your medication and should be avoided. Page 1 of 5

Possible side effects The side effects of dabrafenib and trametinib are different from those experienced by patients receiving chemotherapy. Some are more likely to occur than others. We are all different so we may get different side effects with varying severity. Some side effects are serious and potentially life-threatening. It is important to tell your treating doctor or nurse about any side effects so they can be monitored and treated. Most are temporary and can be managed. Below is a list of possible side effects that can occur. This is a guide only and not an exhaustive list. Common side effects (more than 1 in 10) Fever Fever is a common side effect with dabrafenib and trametinib and usually occurs within the first couple of months of therapy. It can however, occur at any time. Fever is defined as a temperature of more than 38.5 C. You should have a digital thermometer available at home and check your temperature if you feel unwell. Symptoms of fever include shivering, sweats and feeling hot or flushed. If you develop a fever you should contact The Christie Hotline on 0161 446 3658 so the doctor treating you can be informed. If you develop a fever you should stop taking your dabrafenib and trametinib capsules until advised by your treating doctor. You can take paracetamol to help bring your temperature down to normal. Please see additional information sheet Guidance on management of fever. Skin changes Dabrafenib and trametinib can cause other changes to your skin. These include a rash thickening of the palms of the hands and soles of the feet; this may be associated with a tingling sensation new lesions that look like warts (papilloma) changes in old moles. Your doctor may refer you to a skin specialist or dermatologist if necessary. Hair loss Your hair may become thinner or the structure of your hair may change. Painful and stiff joints This treatment can be associated with muscle and joint aches and pains. You may need painkillers to help with this. For mild pain you can take paracetamol or ibuprofen. In some cases your doctor may need to prescribe strong painkillers. Diarrhoea Diarrhoea can occur with this treatment. It is not usually severe and can be managed with an anti-diarrhoeal medication when required. It is also important to remain wellhydrated by drinking water. If you are having more than 4 episodes of diarrhoea per day, are becoming dehydrated or have associated abdominal pains you should contact your doctor or The Christie Hotline on 0161 446 3658. Page 2 of 5

Headache Headache can sometimes occur and can be managed with painkillers. If it is severe you should contact The Christie Hotline as there are other causes of headache that need to be considered. Nausea and loss of appetite If you lose your appetite, try eating small meals. If you are losing weight you might need to see a dietitian or ask your medical team for further advice. Feeling tired Feeling fatigued is a common side effect. You may need to limit your activities to help with this. Do what you feel capable of and take plenty of rest if you need to. Cough You may develop a cough when you have this treatment. It can be eased by drinking warm fluids or your treating doctor may prescribe cough medicines to help. Uncommon side effects (less than 1 in 10) Squamous cell cancers This treatment may cause a type of skin cancer called squamous cell carcinoma (cuscc). These cancers are generally not serious and do not usually spread to other parts of the body. During treatment we will monitor your skin for cuscc. You should also check your skin and if you develop anything of concern, please make sure you inform your treating doctor. Look out for lesions that look like a new wart or a reddish bump that bleeds or does not heal. In some circumstances, these skin cancers need to be removed. Rare side effects (up to 1 in 100) Vision changes The drugs can rarely cause inflammation of part of the eye called uveitis. Please let The Christie Hotline team know immediately if you develop blurred vision, eye pain, swelling, or redness. Serious and potentially life-threatening side effects In a small proportion of patients immunotherapy can result in very severe side effects which may rarely result in death. The team caring for you will discuss the risk of these side effects with you. If you are taking any other medications: Dabrafenib can react with other medications. It is important to let your doctor know if you are on any medications for other conditions or if there are any changes to your medication. Common types of medications which might react with dabrafenib are:- Antibiotics such as rifampicin, clarithromycin, erythromycin. Anti-fungals such a as ketoconazole, fluconazole and itraconazole. Blood pressure medications such as diltiazem and verapamil. Anti-seizure medications such as carbamazepine, phenobarbitone and phenytoin. Drugs taken after a transplant such as cyclosporin. Hormones such as oestrogens and progesterones. St John s Wort. Drugs to reduce stomach acid. Page 3 of 5

Diet You do not need to be on a special diet while on treatment; however, grapefruit and grapefruit juice can interact with your medication and should be avoided. If you are diabetic, dabrafenib can interfere with your blood sugar control. Check your blood sugars regularly. Sex, contraception & fertility We recommend that you or your partner use a condom during sexual intercourse while receiving treatment. It is still possible to become pregnant or father a child while on this treatment. Pregnancy should be avoided as it is unknown whether this treatment is harmful to the unborn baby. Hormonal contraception may not work as well in women taking dabrafenib. Do not breast feed during treatment. Dabrafenib may damage sperm and cause sterility in men. If you plan to have children please discuss this with your doctor before commencing treatment. Late side effects The long term possible side effects of treatment with dabrafenib are not yet known. Please speak to your doctor if you wish to discuss this further. Contacts If you have any general questions or concerns about your treatment, please ring:- Jackie Hodgetts on 0161 446 3868 General enquires on 0161 446 3000 For urgent advice ring The Christie Hotline on 0161 446 3658 (24 hours) Your consultant is:... Your hospital number is:... Your key worker is:... Page 4 of 5

If you need information in a different format, such as easy read, large print, BSL, braille, email, SMS text or other communication support, please tell your ward or clinic nurse. We try to ensure that all our information given to patients is accurate, balanced and based on the most up-to-date scientific evidence. If you would like to have details about the sources used please contact patient.information@christie.nhs.uk 2017 The Christie NHS Foundation Trust. This document may be copied for use within the NHS only on the condition that The Christie NHS Foundation Trust is acknowledged as the creator. For more information about The Christie and our services, please visit www.christie.nhs.uk or visit the cancer information centre at Withington, Oldham or Salford. Contact The Christie Hotline for urgent support and specialist advice The Christie Hotline: 0161 446 3658 Open 24 hours a day, 7 days a week The Christie NHS Foundation Trust Wilmslow Road Withington Manchester M20 4BX Tel: 0161 446 3000 www.christie.nhs.uk The Christie Patient Information Service January 2018 - Review July 2020 CHR/TAR/1194/15.02.17 (Melanoma) Version 2 Page 5 of 5